Sunrise

Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.

We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with unprecedented clinical results. Studies demonstrate Sunrise is as accurate as in-lab sleep studies, at a fraction of the cost.

Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.

Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.

After a successful launch in selected countries and after having validated Sunrise's demand and positioning in the care pathway, the company is now growing strongly.